JP2014511929A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511929A5
JP2014511929A5 JP2014504429A JP2014504429A JP2014511929A5 JP 2014511929 A5 JP2014511929 A5 JP 2014511929A5 JP 2014504429 A JP2014504429 A JP 2014504429A JP 2014504429 A JP2014504429 A JP 2014504429A JP 2014511929 A5 JP2014511929 A5 JP 2014511929A5
Authority
JP
Japan
Prior art keywords
polysaccharide
formula
iii
bond
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014504429A
Other languages
English (en)
Japanese (ja)
Other versions
JP6122418B2 (ja
JP2014511929A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/051768 external-priority patent/WO2012140580A1/en
Publication of JP2014511929A publication Critical patent/JP2014511929A/ja
Publication of JP2014511929A5 publication Critical patent/JP2014511929A5/ja
Application granted granted Critical
Publication of JP6122418B2 publication Critical patent/JP6122418B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014504429A 2011-04-11 2012-04-11 アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用 Active JP6122418B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1153116 2011-04-11
FR1153116 2011-04-11
PCT/IB2012/051768 WO2012140580A1 (en) 2011-04-11 2012-04-11 Polysaccharides comprising two antithrombin iii-binding sites, preparation thereof and use thereof as antithrombotic medicaments

Publications (3)

Publication Number Publication Date
JP2014511929A JP2014511929A (ja) 2014-05-19
JP2014511929A5 true JP2014511929A5 (https=) 2015-04-02
JP6122418B2 JP6122418B2 (ja) 2017-04-26

Family

ID=46025830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014504429A Active JP6122418B2 (ja) 2011-04-11 2012-04-11 アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用

Country Status (7)

Country Link
US (2) US9346894B2 (https=)
EP (1) EP2697265B1 (https=)
JP (1) JP6122418B2 (https=)
AR (1) AR085961A1 (https=)
TW (1) TW201247209A (https=)
UY (1) UY34012A (https=)
WO (1) WO2012140580A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2818871A1 (en) 2013-06-28 2014-12-31 Roche Diagniostics GmbH Means and methods for universal calibration of anti-Factor Xa tests
CN103743837B (zh) * 2013-12-24 2015-01-21 山东泰邦生物制品有限公司 人抗凝血酶ⅲ肝素结合比例检测方法
KR102240937B1 (ko) * 2014-10-10 2021-04-15 삼성디스플레이 주식회사 표시 장치
CN107431362A (zh) * 2014-11-06 2017-12-01 曼蒂斯影像有限公司 提供能量脉冲的电路
JP6741277B2 (ja) * 2015-12-30 2020-08-19 シェンツェン ヘパリンク ファーマスーティカル グループ カンパニー リミテッドＳｈｅｎｚｈｅｎ Ｈｅｐａｌｉｎｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． 硫酸化ヘパリン由来オリゴ糖及びその調製法と施用
CN111175415A (zh) * 2019-12-24 2020-05-19 湖北亿诺瑞生物制药有限公司 一种依诺肝素钠中苄索氯铵残留的测定方法
EP4384819A1 (en) 2021-08-08 2024-06-19 University of Rochester Nanomembrane device and method for biomarker sampling

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663639B1 (fr) 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2889078B1 (fr) 2005-07-27 2007-11-02 Aventis Pharma Sa Nouvelle methode de chromatographie d'affinite d'antithrombine iii

Similar Documents

Publication Publication Date Title
JP2014511929A5 (https=)
Linhardt et al. Oligosaccharide mapping of low-molecular-weight heparins: structure and activity differences
JP5389140B2 (ja) ヘパリン誘導多糖類混合物、その製造およびそれを含有する医薬組成物
RU2617764C2 (ru) Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
JP2015500388A5 (https=)
JP2003522796A5 (https=)
JP6122418B2 (ja) アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用
BRPI0509068B1 (pt) método para quantificar a quantidade de componentes em uma amostra de material selecionado de heparinas não fracionadas e heparinas fracionadas
Zhang et al. Chemical structure and chain conformation of the water‐insoluble glucan isolated from Pleurotus tuber‐regium
JP2008525311A5 (https=)
EP2427501A1 (en) Novel sulfated heptasaccharide and its use as antithrombotic agent
US20120115809A1 (en) Use of an acylated octasaccharide as an antithrombotic agent
JP4865552B2 (ja) ヘパリン−誘導オリゴ糖混合物、その製造およびその混合物を含有する医薬組成物
US20120108542A1 (en) Sulfated octasaccharide and its use as antithrombotic agent
FI3683242T3 (fi) Pentosaanipolysulfaatti ja menetelmä pentosaanipolysulfaatin valmistamiseksi
EP2881404B1 (en) Method for obtaining low molecular weight and very low molecular weight heparins
US7956046B2 (en) Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
WO2015184248A1 (en) Methods of treating fibrotic diseases
CN120344569A (zh) 中等分子量肝素的制备
KR101104107B1 (ko) 헤파린으로부터 유도된 다당류의 혼합물, 이의 제조방법 및이를 함유하는 약제학적 조성물
CN119591746A (zh) 一种羊源高效价比糖胺聚糖混合物及制备方法
CN117304367A (zh) 岩藻糖化硫酸软骨素寡糖的衍生物及其制备方法与应用
HK1206042B (en) Method for obtaining low molecular weight and very low molecular weight heparins
RU2006141290A (ru) Способ обнаружения комплексов между гепаринами и поликатионами
NO890350L (no) Heparinderivater.